Ashton Thomas Private Wealth’s Cerenome, Inc. Common Stock CNSY Stock Holding History

Ashton Thomas Private Wealth’s Portfolio CNSY Stock Details CNSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$150K	Buy	34,306 +32,989	+2,505%	+$180K	﹤0.01%	1203
2026 Q1	$5.35K	Buy	1,317 +320	+32%	+$2.43K	﹤0.01%	1442
2025 Q4	$12.8K	Buy	+997	New	+$15K	﹤0.01%	996
2024 Q4	–	Sell	-517	Closed	-$18.9K	–	807
2024 Q3	$18.9K	Buy	517 +484	+1,467%	+$19.1K	﹤0.01%	614
2024 Q2	$1.2K	Buy	+33	New	+$1.62K	﹤0.01%	1827
2023 Q2	–	Sell	-33	Closed	-$3.55K	–	595
2023 Q1	$3.55K	Hold	33	–	–	﹤0.01%	495
2022 Q4	$3.88K	Hold	33	–	–	﹤0.01%	471
2022 Q3	$5.44K	Hold	33	–	–	﹤0.01%	445
2022 Q2	$6.61K	Buy	+33	New	+$8.24K	﹤0.01%	448

Other funds holding CNSY

APW

Allied Private Wealth Boca Raton, Florida $156M AUM

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.99% 1-Year Est. Return

Ashton Thomas Private Wealth's CNSY Position: Q2 2026 in Review

Ashton Thomas Private Wealth increased its Cerenome, Inc. Common Stock (CNSY) stake by 2,505% in Q2 2026, buying an estimated $180K and bringing the position to 34,306 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #1203.

Ashton Thomas Private Wealth first reported a position in CNSY in Q2 2022 and has held it in 9 quarters since. 5 funds tracked by Wall St. Rank hold CNSY as of Q2 2026.

Ashton Thomas Private Wealth held 34,306 shares of Cerenome, Inc. Common Stock worth $150K as of Q2 2026.
Ashton Thomas Private Wealth bought 32,989 Cerenome, Inc. Common Stock shares in Q2 2026, an estimated $180K.
Cerenome, Inc. Common Stock made up ﹤0.01% of Ashton Thomas Private Wealth's portfolio in Q2 2026, its #1203 holding.
Ashton Thomas Private Wealth first reported a position in Cerenome, Inc. Common Stock in Q2 2022 and has held it in 9 quarters since.
5 funds tracked by Wall St. Rank held Cerenome, Inc. Common Stock as of Q2 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.